The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
Open accessAbstract
Based on the data from large single and multi-center clinical trials, including the Heart Outcomes Prevention Evaluation (HOPE) study, it is clear that the presence of microalbuminuria is a signal from the kidney that cardiovascular risk is increased and that vascular responses are altered. This is exemplified by studies that have demonstrated that the compensatory vaso-dilation seen following relief from prolonged ischemia or infusion of vasodilators such as nitroglycerin is blunted in people with microalbuminuria. Thus, the presence of between 30 and 299 mg/day of albumin in the urine is associated with abnormal vascular responsiveness, which may be the result of more advanced atherosclerosis and not necessarily related to the presence of hypertension or renal disease. Agents known to reduce the rise in microalbuminuria or actually reduce the level of microalbuminuria, such as ACE inhibitors, angiotensin receptor blockers, HMG-CoA reductase inhibitors, beta blockers, non-dihydropyridine calcium channel blockers and diuretics, have all been shown to reduce cardiovascular mortality and in some cases preserve renal function. This article will present an overview of the data that support the assertion that a reduction in the rise of microalbuminuria is a significant consideration in the selection of agents to treat a given risk factor (cholesterol or blood pressure) to a recommended target goal. Achieving such a goal with agents that also impact microalbuminuria will provide for a more complete cardiovascular risk reduction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Banting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440
Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
Mogensen, C. E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100605 · Cited by 1,908
MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS
Viberti, G. C., Jarrett, R. J., Mahmud, U., Hill, R. D., Argyropoulos, A., & Keen, H. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92450-3 · Cited by 1,663
Preserving renal function in adults with hypertension and diabetes: A consensus approach
Bakris, G. L., Williams, M., Dworkin, L., Elliott, W. J., Epstein, M., Toto, R., Tuttle, K., Douglas, J., Hsueh, W., & Sowers, J. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.16225 · Cited by 1,411
Self-citationNowy rok, stare problemy, ale i nowe możliwości
Czupryniak, L., & Diabetologicznego, P. P. T. (2014) · Via Medica Journals · Cited by 1,192
Mogensen, C. E., Neldam, S., Tikkanen, I., Oren, S., Viskoper, R., Watts, R. W., & Cooper, M. E. (2000) · BMJ · doi:10.1136/bmj.321.7274.1440 · Cited by 1,037
MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS
Yudkin, J., Forrest, R., & Jackson, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92657-8 · Cited by 847
Ravid, M., Savin, H., Jutrin, I., Bental, T., Katz, B., & Lishner, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-8-199304150-00001 · Cited by 775
Effect of lipid reduction on the progression of renal disease: A meta-analysis
Fried, L. F., Orchard, T. J., & Kasiske, B. L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00487.x · Cited by 672
Microalbuminuria as predictor of increased mortality in elderly people.
Damsgaard, E. M., Frøland, A., Jørgensen, O. D., & Mogensen, C. E. (1990) · BMJ · doi:10.1136/bmj.300.6720.297 · Cited by 609
Dinneen, S. F. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440340025002 · Cited by 574
Stehouwer, C. A., Zeldenrust, G. C., den Ottolander, G. H., Hackeng, W. H. L., Donker, A. J. M., & Nauta, J. J. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)91401-s · Cited by 560
The Insulin Resistance Atherosclerosis Study (IRAS)
Wagenknecht, L. E., Mayer, E. J., Rewers, M., Haffner, S., Selby, J., Borok, G. M., Henkin, L., Howard, G., Savage, P. J., Saad, M. F., et al. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(95)00062-3 · Cited by 492
Endothelial dysfunction and pathogenesis of diabetic angiopathy
Stehouwer, C. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00272-6 · Cited by 441
Ravid, M., Brosh, D., Levi, Z., Bar-Dayan, Y., Ravid, D., & Rachmani, R. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_1-199806150-00004 · Cited by 389
Microalbuminuria and endothelial dysfunction in essential hypertension
PEDRINELLI, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91047-2 · Cited by 383
Diurnal Variations of Blood Pressure and Microalbuminuria in Essential Hypertension
Bianchi, S., Bigazzi, R., Baldari, G., Sgherri, G., & Campese, V. M. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.1.23 · Cited by 369
Marre, M., Bernadet, P., Gallois, Y., Savagner, F., Guyene, T.-T., Hallab, M., Cambien, F., Passa, P., & Alhenc-Gelas, F. (1994) · Diabetes · doi:10.2337/diab.43.3.384 · Cited by 366
Messent, J. W. C., Elliott, T. G., Hill, R. D., Jarrett, R. J., Keen, H., & Viberti, G. (1992) · Kidney International · doi:10.1038/ki.1992.128 · Cited by 328
Ravid, M. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440030080010 · Cited by 314
H. Bennett, P., Haffner, S., Kasiske, B. L., Keane, W. F., Mogensen, C. E., Parving, H.-H., Steffes, M. W., & Striker, G. E. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90636-3 · Cited by 297
Hyperinsulinemic Microalbuminuria: A New Risk Indicator for Coronary Heart Disease
Kuusisto, J., Mykkänen, L., Pyörälä, K., & Laakso, M. (1995) · Circulation · doi:10.1161/01.cir.91.3.831 · Cited by 232
Clausen, P., Jensen, J. S., Jensen, G., Borch-Johnsen, K., & Feldt-Rasmussen, B. (2001) · Circulation · doi:10.1161/01.cir.103.14.1869 · Cited by 231
Cirillo, M., Senigalliesi, L., Laurenzi, M., Alfieri, R., Stamler, J., Stamler, R., Panarelli, W., & De Santo, N. G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.17.1933 · Cited by 228
Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
Lebovitz, H. E., Wiegmann, T. B., Cnaan, A., Shahinfar, S., Sica, D. A., Broadstone, V. L., Schwartz, S. L., Mengel, M. C., Segal, R., & Versaggi, J. A. (1994) · PubMed · Cited by 219
Prevalence and Clinical Correlates of Microalbuminuria in Essential Hypertension: The MAGIC Study
Pontremoli, R., Sofia, A., Ravera, M., Nicolella, C., Viazzi, F., Tirotta, A., Ruello, N., Tomolillo, C., Castello, C., Grillo, G., et al. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1135 · Cited by 215
Mykkänen, L., Zaccaro, D. J., O’Leary, D. H., Howard, G., Robbins, D. C., & Haffner, S. M. (1997) · Stroke · doi:10.1161/01.str.28.9.1710 · Cited by 203
Microalbuminuria: Implications for micro- and macrovascular disease
Deckert, T., Kofoed-Enevoldsen, A., Nørgaard, K., Borch-Johnsen, K., Feldt-Rasmussen, B., & Jensen, T. (1992) · Diabetes Care · doi:10.2337/diacare.15.9.1181 · Cited by 192
Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension
Agrawal, B., Berger, A., Wolf, K., & Luft, F. C. (1996) · Journal of Hypertension · doi:10.1097/00004872-199602000-00011 · Cited by 191
Bianchi, S., Bigazzi, R., & Campese, V. M. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70002-8 · Cited by 188
Agewall, S., Wikstrand, J., Ljungman, M., & Fagerberg, B. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00312-3 · Cited by 184
Martin, M., Neumann, D., Hoff, T., Resch, K., DeWitt, D. L., & Goppelt-Struebe, M. (1994) · Kidney International · doi:10.1038/ki.1994.18 · Cited by 178
The Natural Course of Microalbuminuria in Insulin‐dependent Diabetes: A 10‐year Prospective Study
Mathiesen, E. R., Rønn, B., Storm, B., Foght, H., & Deckert, T. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00528.x · Cited by 178
MICA Polymorphism Is Associated With Type 1 Diabetes in the Korean Population
Park, Y., Lee, H., Sanjeevi, C. B., & Eisenbarth, G. S. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.33 · Cited by 165
Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study
Hoogeveen, E. K., Kostense, P. J., Jager, A., Heine, R. J., Jakobs, C., Bouter, L. M., Donker, A. J. M., & Stehouwer, C. D. A. (1998) · Kidney International · doi:10.1038/sj.ki.4495353 · Cited by 160
Microalbuminuria and associated cardiovascular risk factors in the community
Winocour, P. H., Harland, J., Millar, J. P., Laker, M. F., & Alberti, K. G. M. M. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90201-q · Cited by 159
Proteinuria and Mortality in Diabetes: the WHO Multinational Study of Vascular Disease in Diabetes
Stephenson, J., Kenny, S., Stevens, L. K., Fuller, J., Lee, E., & WHO Multinational Study Group (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00446.x · Cited by 149
Redón, J., Liao, Y., Lozano, J. V., Miralles, A., Pascual, J. M., & Cooper, R. (1994) · PubMed · Cited by 141
Microalbuminuria is an early response following acute myocardial infarction
Gosling, P. J., Hughes, E., Reynolds, T., & FOX, J. P. (1991) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059931 · Cited by 136
Bigazzi, R., Bianchi, S., Nenci, R., Baldari, D., Baldari, G., & Campese, V. M. (1995) · PubMed · Cited by 122
Sano, T., Kawamura, T., Matsumae, H., Sasaki, H., Nakayama, M., Hara, T., Matsuo, S., Hotta, N., & Sakamoto, N. (1994) · Diabetes Care · doi:10.2337/diacare.17.5.420 · Cited by 120
U.K. Prospective Diabetes Study
Turner, R. C., Cull, C. A., & Holman, R. R. (1996) · Diabetes Care · doi:10.2337/diacare.19.2.182 · Cited by 118
Ambulatory blood pressure and microalbuminuria in essential hypertension
Redón, J., Liao, Y., Lozano, J. V., Miralles, A., Pascual, J. M., & Cooper, R. (1994) · Journal of Hypertension · doi:10.1097/00004872-199408000-00013 · Cited by 112
Microalbuminuria in Patients With NIDDM: An Overview
Alzaid, A. (1996) · Diabetes Care · doi:10.2337/diacare.19.1.79 · Cited by 110
Gaber, L. W., Walton, C., Brown, S. A., & Bakris, G. L. (1994) · Kidney International · doi:10.1038/ki.1994.255 · Cited by 105
Self-citationJensen, J., Feldt‐Rasmussen, B., Borch‐Johnsen, K., Clausen, P., Appleyard, M., & Jensen, G. (1997) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000459 · Cited by 100
Ravid, M., Neumann, L., & Lishner, M. (1995) · Kidney International · doi:10.1038/ki.1995.135 · Cited by 100
Microalbuminuria: a marker of systemic disease.
Gosling, P. J. (1995) · PubMed · Cited by 99
Renal and Systemic Transvascular Albumin Leakage in Severe Atherosclerosis
Jensen, J. S. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1324 · Cited by 98
(1994) · Diabetes Care · doi:10.2337/diacare.17.11.1357 · Cited by 96
Factors Related to the Presence of Microalbuminuria in Essential Hypertension
Redón, J., Liao, Y., Lozano, J. V., Miralles, A., Baldó, E., & Cooper, R. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.9.801 · Cited by 94
Pontremoli, R., Sofia, A., Tirotta, A., Ravera, M., Nicolella, C., Viazzi, F. C., Bezante, G. P., Borgia, L., Bobola, N., Ravazzolo, R., et al. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122550 · Cited by 93
Albuminuria in normals and essential hypertension
Mimran, A., Ribstein, J., DuCailar, G., & Halimi, J. (1994) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(94)90032-9 · Cited by 91
Dudley, C. R. K., Keavney, B. D., STRATTON, I. M., Turner, R. C., & Ratcliffe, P. J. (1995) · Kidney International · doi:10.1038/ki.1995.490 · Cited by 84
Palatini, P. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00391-6 · Cited by 81
Evidence of oxidant injury and tubular damage in early diabetic nephropathy
Yaqoob, M. M., McClelland, P. D., Patrick, A. W., Stevenson, A., Mason, H. J., White, M. C., & Bell, G. M. (1994) · QJM · doi:10.1093/oxfordjournals.qjmed.a068872 · Cited by 81
Microalbuminuria: prognostic implications
Bakris, G. L. (1996) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199605000-00006 · Cited by 73
Self-citationBakris, G. L., Slataper, R., Vicknair, N., & Sadler, R. (1994) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(94)90003-5 · Cited by 67
Self-citationMicro-albuminuria as a predictor of cardiovascular damage in essential hypertension
Cerasola, G., Cottone, S., Dʼlgnoto, G., Grasso, L., Mangano, M. T., Carapelle, E., Nardi, E., Andronico, G., Fulantelli, M. A., Marcellino, T., et al. (1989) · Journal of Hypertension · doi:10.1097/00004872-198900076-00162 · Cited by 67
Biesenbach, G., & Zazgornik, J. (1994) · PubMed · Cited by 57
Pedrinelli, R., Bello, V. D., Catapano, G., Talarico, L., Materazzi, F., Santoro, G., Giusti, C., Mosca, F., Melillo, E., & Ferrari, M. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.900 · Cited by 55
Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.
Sibley, S. D., Hokanson, J. E., Steffes, M. W., Purnell, J. Q., Marcovina, S. M., Cleary, P. A., & Brunzell, J. D. (1999) · Diabetes Care · doi:10.2337/diacare.22.7.1165 · Cited by 54
Epidemiology of microalbuminuria in diabetes and in the background population
Mogensen, C. E., & Poulsen, P. L. (1994) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199405000-00004 · Cited by 45
Assessment of intermittent claudication by quantitation of exercise induced microalbuminuria
Hickey, N. C., Shearman, C. P., Gosling, P. J., & Simms, M. H. (1990) · European Journal of Vascular Surgery · doi:10.1016/s0950-821x(05)80815-1 · Cited by 45
Bakris, G. L., & Williams, B. (1995) · Journal of Hypertension · doi:10.1097/00004872-199508001-00016 · Cited by 44
Self-citationDiabetic Nephropathy: Future avenue
Viberti, G. C., Messent, J. W. C., & Morocutti, A. (1992) · Diabetes Care · doi:10.2337/diacare.15.9.1216 · Cited by 43
Microalbuminuria in essential hypertension--its relation to cardiovascular risk factors
Pontremoli, R. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027119 · Cited by 39
Schmitz, A. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00152-0 · Cited by 38
Halimi, J.-M., Forhan, A., Balkau, B., Novak, M., Wilpart, E., Tichet, J., & Marre, M. (2001) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670100800304 · Cited by 33
Microalbuminuria as a marker of cardiovascular and renal disease in essential hypertension
Bigazzi, R., & Bianchi, S. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.supp6.10 · Cited by 31
Update on pathogenesis, markers and management of diabetic nephropathy
Mogyor??si, A., & Ziyadeh, F. N. (1996) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199605000-00010 · Cited by 28
Lipoprotein(a) in Type 1 Diabetic Patients with Renal Disease
Groop, P., Viberti, G. C., Elliott, T. G., Friedman, R., Mackie, A., Ehnholm, C., Jauhiainen, M., & Taskinen, M. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00254.x · Cited by 23
Localization of advanced glycation endproducts in the kidney of experimental diabetic rats
Shikata, K., Makino, H., Sugimoto, H., Kushiro, M., Ota, K., Akiyama, K., Araki, N., Horiuchi, S., & Ota, Z. (1995) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(95)80019-b · Cited by 22
Microalbuminuria and cardiovascular risk: a word of caution
Gosling, P. J. (1998) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000594 · Cited by 17
Microalbuminuria: A Genetic Link Between Diabetes and Cardiovascular Disease?
Yudkin, J. S. (1992) · Annals of Medicine · doi:10.3109/07853899209167005 · Cited by 16
Microalbuminuria: Pathogenesis, Prognosis and Management
Panayiotou, B. (1994) · Journal of International Medical Research · doi:10.1177/030006059402200401 · Cited by 12
Zouvanis, M., Raal, F. J., Joffe, B. I., & Seftel, H. C. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05443-m · Cited by 9
Microalbuminuria in hypertension: Is it up to measure?
Lydakis, C., Efstratopoulos, A., & Lip, G. Y. H. (1997) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000503 · Cited by 5
Cited by
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Self-citationStandards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
“It is also a wellestablished marker of increased CVD risk (331,332).”
BackgroundStandards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Metadata
- Authors
- Garg, J. P., & Bakris, G. L.
- Venue
- Vascular Medicine
- Publisher
- SAGE Publications
- Published
- 2002-02
- Volume
- 7
- Issue
- 1
- Pages
- 35-43
- ISSN
- 1358-863X (ISSN-L)
- 1477-0377
- OpenAlex
- W2166286680
- Cited by
- 278
- References
- 87
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.